DMAC

MKT CAP:$315M

DiaMedica Therapeutics Inc

Market Cap

$315M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$5.64-$2.29 (-28.88%)

Jun 5, 2026

52W High $9.3952W Low $3.51

Company Details

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human ...

CEO

—

IPO Date

Jan 4, 2008

Website

www.diamedica.com

Key Metrics TTM

Revenue

-$28.0K

-100.2% YoY

Net Income

-$35M

EPS (Diluted)

Free Cash Flow

-$31M

Revenue / Share

-$0.00

Gross Margin

164.3%

Operating Margin

131201.1%

Net Margin

125365.2%

FCF Margin

111025.6%

P/S

P/E

Earnings Reports

Q1 2026

May 6, 2026

FY 2025

Mar 30, 2026

Q4 2025

Mar 30, 2026

-$28.0K-100.2%

Q3 2025

Nov 12, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee